z-logo
open-access-imgOpen Access
PMON169 D2R Expression in Dopamine-Agonist Resistant Prolactinomas
Author(s) -
Alice C. Levine,
Ilana R Bass,
Eva de Alba,
Melissa Umphlett,
William P. Shuman,
Emily Milgrim,
Lucas Milgrim,
Joshua B. Bederson,
Kalmon D. Post,
Raj Shrivastava
Publication year - 2022
Publication title -
journal of the endocrine society
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/jendso/bvac150.1139
Subject(s) - cabergoline , prolactinoma , dopamine agonist , tmprss2 , prolactin cell , prolactin , agonist , medicine , endocrinology , cancer research , dopamine receptor d2 , prostate cancer , biology , oncology , cancer , dopamine , receptor , hormone , disease , covid-19 , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom